Sierra Oncology's Bridge - II Round

Sierra Oncology raised a round of funding on June 04, 2013.

Sierra Oncology, formerly ProNAi Therapeutics, is applying nucleic acid-based DNA interference technology (DNAi) to discover and develop therapeutic approaches for cancer and other diseases. The compa…

Articles about Sierra Oncology's Bridge - II Round: